| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.3 | Approve the Dividend | For |
| O.4 | Ratify Appointment of Elie Girard as Director | For |
| O.5 | Ratify Appointment of Cedrik Neike as Director | For |
| O.6 | Reelect Nicolas Bazire as Director | Oppose |
| O.7 | Reelect Valerie Bernis as Director | Abstain |
| O.8 | Reelect Colette Neuville as Director | For |
| O.9 | Reelect Cedrik Neike as Director | Oppose |
| O.10 | Elect Jean Fleming as Representative of Employee Shareholders to the Board | For |
| O.11 | Appoint the Auditors | Oppose |
| O.12 | Acknowledge End of Mandate of IGEC as Alternate Auditor and Decision Not to Replace | For |
| O.13 | Approve Transaction with Worldline Re: Separation Agreement | For |
| O.14 | Approve Compensation of Thierry Breton, Chairman and CEO Until Oct. 31, 2019 | For |
| O.15 | Approve Compensation of Bertrand Meunier, Chairman of the Board Since Nov. 1, 2019 | For |
| O.16 | Approve Compensation of Elie Girard, Vice-CEO Since April 2, 2019 Until Oct. 31, 2019 | Oppose |
| O.17 | Approve Compensation of Elie Girard, CEO Since Nov. 1, 2019 | Oppose |
| O.18 | Approve Compensation Report of Corporate Officers | Oppose |
| O.19 | Approve Remuneration Policy of Directors | For |
| O.20 | Approve Remuneration Policy of Chairman of the Board | For |
| O.21 | Approve Remuneration Policy of CEO | Oppose |
| O.22 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Oppose |
| E.23 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares | For |
| E.24 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to 30 Percent of Issued Share Capital | For |
| E.25 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to 10 Percent of Issued Share Capital | Oppose |
| E.26 | Approve Issuance of Equity or Equity-Linked Securities for up to 10 Percent of Issued Capital Per Year for Private Placements | Oppose |
| E.27 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | For |
| E.28 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Oppose |
| E.29 | Authorize Capitalization of Reserves of Up to EUR 5,111 Million for Bonus Issue or Increase in Par Value | For |
| E.30 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Oppose |
| E.31 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of International Subsidiaries | Oppose |
| E.32 | Authorize up to 0.9 Percent of Issued Capital for Use in Restricted Stock Plans | Oppose |
| E.33 | Amend Article 16 of Bylaws Re: Employee Representative | For |
| E.34 | Amend Articles 20 and 26 of Bylaws Re: Board Remuneration | For |
| E.35 | Amend Article 18 of Bylaws Re: Written Consultation | For |
| E.36 | Amend Article 10 of Bylaws Re: Shareholding Disclosure Thresholds | For |
| E.37 | Authorize Filing of Required Documents/Other Formalities | For |
